Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.75
+0.47 (3.54%)
At close: Apr 28, 2026, 4:00 PM EDT
13.71
-0.04 (-0.29%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Enanta Pharmaceuticals Employees
Enanta Pharmaceuticals had 120 employees as of September 30, 2025. The number of employees decreased by 11 or -8.40% compared to the previous year.
Employees
120
Change (1Y)
-11
Growth (1Y)
-8.40%
Revenue / Employee
$558,167
Profits / Employee
-$596,142
Market Cap
399.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Niagen Bioscience | 117 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 53 |
ENTA News
- 15 days ago - Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria - Business Wire
- 21 days ago - Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026 - Business Wire
- 4 weeks ago - Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI) - Business Wire
- 2 months ago - Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference - Business Wire
- 2 months ago - Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting - Business Wire
- 2 months ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 - Business Wire
- 3 months ago - Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook - Business Wire
- 4 months ago - Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire